Great strides have been made within pre-clinical research and discovery efforts that inform and enable an oncology development program based on CRISPR/Cas9 gene editing techniques, but there remains much to consider when it comes to implementing an early phase clinical trial.
Read our white paper – the second in a series to learn more.
Read the first paper in this CRISPR series:
CRISPR, Gene-Based Therapeutics, and Clinical Trials
and
